#psychiary

Serial Ketamine Infusions for Depression This randomized clinical trial evaluates outcomes following adjunctive ketamine infusions vs midazolam for depression.

New 6-month depression RCT in n=65, serial Ketamine infusions as adjunctive care vs active placebo midazolam.

Ketamine did not outperform primary nor any of the secondary efficacy, cognitive, economic, or quality-of-life outcomes.

🧪 #psychiary #PsychSciSky

jamanetwork.com/journals/jam...